Skip to content
MARKET
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
Barakfi
⌕/

Menu

⌂Home⌕Screener⊞Compare
TermsPrivacyDisclaimerShariah
Theme
Screener
WatchlistPortfolio
Log inGet started
⌂Home⌕Screener☆Watchlist▦Portfolio
Home/Screener/BIOCON
NSEPharmaceuticalsIndia
BIOCON logo

Biocon Limited

Non-Compliant
₹352

-3.61% today · Day ₹342 – ₹363 · NSE (public)

4/6Pass

This stock doesn't meet 1 Shariah rule. See below to understand why.

80/100
Non-Compliant

This stock doesn't meet 1 Shariah rule. See below to understand why.

Market Cap₹57,090
Revenue₹15,052
Total Debt₹18,362
Debt / Mcap35.74%
Non-Halal Income0.72%
SectorPharmaceuticals
✦
Pharmaceuticals›Pharmaceuticals
▲
Mid Cap›Market cap of ₹57,090
⇅
Higher Risk›Debt ratio 35.74%
Ad
Price Chart
Loading chart...
52-Week Range42% from low
₹299₹352₹425
52-Week Low₹299
52-Week High₹425
Prev Close₹365

Multi-Methodology Screening

Screened against 3 international Shariah standards

ConsensusNon-Compliant0/3 pass
S&P Shariah IndicesNon-Compliant
Debt Ratio35.7%/ 33.0%
Non-Halal Income0.7%/ 5.0%
Interest Income0.7%/ 5.0%
Receivables9.6%/ 33.0%
Cash & IB Securities8.4%/ 33.0%
SectorAllowed

Debt is 35.7% of 36m avg market cap (limit: <33%).

AAOIFI StandardsNon-Compliant
Debt Ratio31.2%/ 30.0%
Non-Halal Income0.7%/ 5.0%
Interest Income0.7%/ 5.0%
Receivables9.3%/ 49.0%
Cash & IB Securities8.4%/ 30.0%
SectorAllowed

Debt is 31.2% of total assets (limit: <30%).

Debt is 31.2% of current total assets (limit: <30%).

FTSE Yasaar (Maxis)Cautious
Debt Ratio31.2%/ 33.0%
Non-Halal Income0.7%/ 5.0%
Interest Income0.7%/ 5.0%
Receivables9.3%/ 50.0%
Cash & IB Securities8.4%/ 33.0%
SectorAllowed

Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.

Compliance check

Green = safe, amber = close to limit, red = over the limit

Debt level
35.74%
How much debt the company carriesLimit: 33.00%
Current debt
32.16%
Debt compared to current company valueLimit: 33.00%
Income purity
0.72%
How much income comes from non-halal sourcesLimit: 5.00%
Interest earned
0.72%

Similar stocks

Other stocks in Pharmaceuticals

SUNPHARMA logo
SUNPHARMASun Pharmaceutical Industries Limited
Cautious
₹1,694-3.61%
₹4.1 L
DIVISLAB logo
DIVISLABDivi's Laboratories Limited
Halal
₹5,857-3.61%
₹1.6 L
TORNTPHARM logo
TORNTPHARMTorrent Pharmaceuticals Limited
Halal
₹3,987-3.61%
₹1.3 L
LUPIN logo
LUPIN
Interest income as portion of total revenueLimit: 5.00%
Money owed to company
9.61%
Outstanding receivables compared to company valueLimit: 33.00%
Cash & interest-bearing
8.37%
Cash and interest-bearing securities as a portion of total assetsLimit: 33.00%
Fixed Assets / Total Assets
23.14%
Asset composition indicatorNo hard threshold

Screening rules

Why it screened this way

✗

Debt is 35.7% of 36m avg market cap (limit: <33%).

Screening results indicate whether this stock meets specific methodology criteria. They do not constitute a fatwa or religious ruling. Consult a qualified Shariah scholar for definitive guidance. View methodology
Lupin Limited
Cautious
₹2,275-3.61%
₹1.0 L